Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Different ways to regulate the PPARalpha stability.

Christophe Blanquart1, Roxane Mansouri, Jean-Charles Fruchart

  • 1INSERM UR-545, Département d'Athérosclérose, Institut Pasteur de Lille, 1 rue du Pr. Calmette, 59019 Lille, France.

Biochemical and Biophysical Research Communications
|June 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment.

Molecular metabolism·2020
Same author

Electrothermal patches driving the transdermal delivery of insulin.

Nanoscale horizons·2020
Same author

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis.

Diabetes, obesity & metabolism·2020
Same author

Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK.

Hepatology communications·2020
Same author

Microbiome Modulation of the Host Adaptive Immunity through Bile Acid Modification.

Cell metabolism·2020
Same author

Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort study.

Neurology·2020
Same journal

Quercetin suppresses TGF-β1-induced proliferation and migration of vascular smooth muscle cells via the Smad2/3/MMP-9 signaling axis.

Biochemical and biophysical research communications·2026
Same journal

Biosynthesis, characterization and biological potential of microbe-mediated silver nanoparticles using thermophilic actinomycetes, Streptomyces nigra.

Biochemical and biophysical research communications·2026
Same journal

COP9 signalosome 8 mediated autophagy drives proliferation, invasion, and metastasis in pancreatic ductal adenocarcinoma.

Biochemical and biophysical research communications·2026
Same journal

Tumor budding in colorectal cancer: partial EMT, microenvironmental remodeling, and metastatic competence.

Biochemical and biophysical research communications·2026
Same journal

Exploring the therapeutic versatility and multitarget pharmacological potential of acyl hydrazone-hydrazide scaffolds.

Biochemical and biophysical research communications·2026
Same journal

The plasma membrane H<sup>+</sup>-ATPase OSA2 negatively regulates salt tolerance in rice seedlings.

Biochemical and biophysical research communications·2026
See all related articles

Peroxisome proliferator-activated receptor alpha (PPARalpha) protein stability is regulated by its interactions and phosphorylation. Corepressor N-CoR binding stabilizes PPARalpha, enhancing its activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Metabolism

Background:

  • Peroxisome proliferator-activated receptor alpha (PPARalpha) is a key transcription factor regulating lipid and glucose metabolism and inflammation.
  • PPARalpha is a short-lived protein targeted for degradation by the ubiquitin-proteasome system.
  • Understanding PPARalpha's stability is crucial for comprehending its regulatory roles.

Purpose of the Study:

  • To investigate how interactions with RXRalpha, CBP, and N-CoR affect PPARalpha ubiquitination and stability.
  • To determine the role of phosphorylation in modulating PPARalpha ubiquitination and protein half-life.
  • To elucidate the mechanisms controlling PPARalpha protein turnover and transcriptional activity.

Main Methods:

  • Co-immunoprecipitation assays to study protein interactions.

Related Experiment Videos

  • Western blotting to assess protein levels and ubiquitination.
  • Treatment with phosphatase inhibitors to analyze phosphorylation effects.
  • Reporter gene assays to measure transcriptional activity.

    • Main Results:

    • Interaction with RXRalpha or CBP accelerates PPARalpha degradation.
    • Binding to the corepressor N-CoR stabilizes PPARalpha and inhibits its transcriptional activity.
    • Inhibition of Ser/Thr phosphatases leads to PPARalpha hyperphosphorylation, increased transcriptional activity, and protein stabilization.
    • Post-translational modifications and cofactor interactions significantly impact PPARalpha stability.

    Conclusions:

    • PPARalpha protein stability is dynamically regulated by its interactions with other proteins and post-translational modifications like phosphorylation.
    • Heterodimerization with RXRalpha or recruitment of CBP promotes PPARalpha turnover.
    • Interaction with N-CoR stabilizes PPARalpha, suggesting a mechanism for transcriptional repression.
    • Phosphorylation status plays a critical role in balancing PPARalpha activity and stability.